# IL-6 Regulation of Substrate Metabolism and Influence of Obesity

> **NCT03967691** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 22 (actual)

## Conditions studied

- Obesity
- Healthy

## Interventions

- **DRUG:** Tocilizumab infusion
- **DRUG:** Saline 0.9%

## Key facts

- **NCT ID:** NCT03967691
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-12
- **Primary completion:** 2020-04-03
- **Final completion:** 2020-04-03
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03967691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03967691, "IL-6 Regulation of Substrate Metabolism and Influence of Obesity". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03967691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*